HEARING
Science and Mission at Risk: FDA’s Self-Assessment
Subcommittee on Oversight and Investigations
Tuesday, January 29, 2008, 10:00 a.m.
2123 Rayburn House Office Building
Hearing Webcast
(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)
Connect to the Archived Video Webcast of this Hearing or Download
Windows Media Player is required to view Committee Web casts.
Note: A version for Mac users is available on Microsoft's Web site.
Witness List & Prepared Testimony
Please click on the name of the witness to link to their prepared testimony. The testimony is available in Adobe pdf file format.
Panel I |
|
Gail H. Cassell, Ph.D.
Vice President, Scientific Affairs and
Distinguished Lilly Research Scholar
for Infectious Diseases
Eli Lilly and Company
Lilly Corporate Center, DC 1050
Indianapolis, IN 46285
|
Mr. Peter Barton Hutt
Covington & Burling LLP
1201 Pennsylvania Avenue, NW
Washington, DC 20004
Attachment |
Catherine E. Woteki, Ph.D.
Global Director of Scientific Affairs
Mars, Inc.
6885 Elm Street
McLean, VA 22101–3883
|
Dale Nordenberg, M.D.
Managing Director
Healthcare Industry Advisory
PriceWaterhouseCoopers
10 Tenth Street, Suite 1400
Atlanta, GA 30309 |
Garret A. FitzGerald, M.D.
Professor of Medicine and Professor and Chair of Pharmacology
Department of Pharmacology
University of Pennsylvania School of Medicine
153 Johnson Pavilion
3620 Hamilton Walk
Philadelphia, PA 19104–6084
|
|
Panel II |
|
Marcia G. Crosse, Ph.D.
Director, Health Care
U.S. Government Accountability Office
441 G Street, NW, Room 5K21
Washington, DC 20548
|
Ms. Lisa Shames
Director
Food and Agriculture Issues
U.S. Government Accountability Office
441 G Street N.W., Room 2T23A
Washington, DC 20548 |
Donna V. Porter, Ph.D., R.D.
Specialist in Food Safety and Nutrition Domestic Social Policy Division
Congressional Research Service
Library of Congress
101 Independence Ave., SE
Washington, DC 20540–7460
|
|
Panel III
|
|
The Honorable Andrew C. von Eschenbach, M.D.
Commissioner
Food and Drug Administration
U.S. Department of Health and
Human Services
5600 Fishers Lane
Rockville, MD 20857
|
|
Hearing Transcript
Not available at this time. The printed hearing should be available within 90-120 days of the conclusion of the hearing. When available, the text of the printed hearing may be viewed at the U.S. Government Printing Office Web site. |